Skip to content
Apex Nursing

Chart — Critical Care

ECMO Comparison Chart

VV ECMO vs. VA ECMO — support type, cannula sites, indications, complications, and nursing monitoring differences side-by-side.

Educational use only. ECMO management is directed by specialized teams under strict institutional protocols; this comparison supports concept review only. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

VV ECMO

Veno-Venous ECMO

Respiratory Support Only

Drains blood from venous system, oxygenates it, returns it to venous circulation. Heart must still pump. Used for severe respiratory failure.

VA ECMO

Veno-Arterial ECMO

Cardiac + Respiratory Support

Drains blood from venous system, oxygenates it, returns it to arterial circulation. Provides cardiac output support. Used for cardiogenic shock and cardiac arrest.

Feature-by-Feature Comparison

FeatureVV ECMOVA ECMO
Support TypeRespiratory only (gas exchange)Cardiac + Respiratory (gas exchange + cardiac output)
Circuit PathVein → Oxygenator → VeinVein → Oxygenator → Artery
Heart Bypassed?No — native heart still pumpsPartially or fully — circuit provides cardiac output
Lungs Bypassed?Yes — ECMO provides gas exchangeYes — ECMO provides gas exchange
Peripheral Drainage SiteFemoral vein or right internal jugularFemoral vein
Peripheral Return SiteRight atrium (jugular or femoral vein)Femoral artery
Typical ECMO Flow3–5 L/min4–6 L/min
Primary IndicationSevere ARDS, refractory hypoxemiaCardiogenic shock, refractory cardiac arrest (eCPR), post-cardiotomy failure
Recirculation RiskYes (oxygenated return re-enters drainage)No
Harlequin (North-South) SyndromeNoYes — upper body may receive hypoxic blood from native cardiac ejection
Limb Ischemia RiskLowHigh — femoral artery cannula obstructs distal flow; distal perfusion catheter usually placed
LV Distension RiskNoYes — retrograde arterial flow increases LV afterload; may need LV venting (Impella or septostomy)
Pulse WaveformNormal (heart pumping)Dampened / pulseless (circuit provides flow; limited by residual native cardiac output)
AnticoagulationHeparin; ACT 180–220 sec (protocol-dependent)Heparin; ACT 180–220 sec (protocol-dependent)
Primary SpO₂ MonitoringPulse oximetry (single site acceptable)Right radial SpO₂ (upper body) AND left pedal SpO₂ (lower body) — detect Harlequin syndrome
Bleeding RiskHigh (anticoagulation)High (anticoagulation + arterial access)
Weaning IndicatorImproved lung compliance; tolerance of FiO₂ reduction and sweep gas reductionImproving native cardiac function on echo; tolerance of flow reduction

Complication Summary

ComplicationVV ECMOVA ECMO
BleedingHigh risk (anticoagulation required)High risk (anticoagulation + arterial site)
Thromboembolism / StrokeRiskHigher risk (arterial return; higher thromboembolic burden)
Limb IschemiaLowSignificant risk (femoral artery cannula)
Harlequin SyndromeNot applicablePresent in peripheral VA ECMO when native cardiac output is hypoxic
LV DistensionNot applicableRisk from retrograde arterial flow increasing LV afterload
RecirculationRisk (especially with femoral-femoral configuration)Not applicable (different vascular compartments)
InfectionRisk (large-bore cannulas, prolonged therapy)Risk (large-bore cannulas, prolonged therapy)

Key Pearls

  • VV ECMO = lung support only; VA ECMO = heart + lung support.
  • In VA ECMO: check BOTH right radial AND pedal SpO₂ to detect Harlequin syndrome.
  • Limb ischemia is a VA-specific complication — check hourly distal pulse/Doppler; a distal perfusion catheter (DPC) does not guarantee perfusion.
  • LV distension in VA ECMO may require an Impella or atrial septostomy to unload the left ventricle.
  • Recirculation (in VV ECMO) reduces effective oxygenation — repositioning cannulas or adjusting flow may be required.
  • Bleeding is the most common complication of both configurations — monitor ACT and all access sites closely.

Standards & sources

Fact-checked Jun 20, 2026

This page is written to align with Society of Critical Care Medicine (SCCM) · Surviving Sepsis Campaign · American Association of Critical-Care Nurses (AACN). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →